¨
U. Yılmaz et al.
activity against Gram-positive bacteria with MIC value 50 µg ml−1
Compound I also showed the highest activity against Gram-
negative bacteria E. coli with MIC value 200 µg ml−1
.
[7] E. A. B. Kantchev, C. J. O’Brien, M. G. Organ, Angew. Chem. Int. Ed.
2007, 46, 2768.
[8] C. S. Linninger, E. Herdtweck, S. D. Hoffmann, W. A. Herrmann,
J. Mol. Struct. 2008, 890, 192.
.
As can be seen from Table 5, all compounds were found to be
effective against C. tropicalis, with a range of MICs between 25
and 50 µg ml−1. Among the tested compounds, I also showed the
highest antifungal activity against C. albicans and C. tropicalis with
MIC values of 6.25 µg ml−1. Compounds 2 and 4 also exhibited
significant antifungal activity against C. albicans and C. tropicalis
with a range of MICs between 25 and 50 µg ml−1. From the data
obtained in this work, it is suggested that increased hydrophobic
character of the benzimidazole derivatives may play some role in
the antimicrobial activities.
[9] R. Singh, M. S. Viciu, N. Kramareva, O. Navarro, S. P. Nolan, Org. Lett.
2005, 7, 1829.
[10] N. Marion, S. P. Nolan, Accounts Chem. Res. 2008, 41, 1440.
[11] F. E. Hahn, M. C. Jahnke, T. Pape, Organometallics 2006, 25, 5927.
[12] E. C¸etinkaya, P. B. Hitchock, H. Ku¨c¸u¨kbay, M. F. Lappert, S. Al-Juaid,
J. Organomet. Chem. 1994, 481, 89.
[13] H. Ku¨c¸u¨kbay,B. C¸etinkaya,S. Guesmi,P. H. Dixneuf, Organometallics
1996, 5, 2434.
[14] B. C¸etinkaya,
E. C¸etinkaya,
J. A. Chamizo,
P. H. Hitchcock,
H. A. Jasim, H. Ku¨c¸u¨kbay, M. F. Lappert, J. Chem. Soc., Perkin
Trans. 1 1998, 2047.
[15] H. Ku¨c¸u¨kbay, E. C¸etinkaya, B. C¸etinkaya and M. F. Lappert, Synth.
Commun. 1997, 27, 4059.
¨
[16] Y. Go¨k, N. Gu¨rbu¨z, Y. Ozdemir, B. C¸etinkaya, E. C¸etinkaya, Appl.
Organomet. Chem. 2005, 19, 870.
Conclusion
¨
[17] S. Demir, I. Ozdemir, B. C¸etinkaya, Appl.Organomet.Chem. 2006, 20,
254.
We prepared one 1-substituted benzimidazole (1) and six
benzimidazole salts containing trimethylsilylmethyl substituent
(2–7). The use of the palladium catalyst system including
benzimidazolium salts in Suzuki coupling reaction gives better
yield under microwave-assisted conditions and short reaction
times compared with those given in literature.
The Suzuki coupling reactions were carried out using 300 W
power microwave irradiation at 120 ◦C in 10 min. The precatalysts
used in this work were prepared from the corresponding
benzimidazole salts (2–7) directly, thereby avoiding the handling
of an isolated highly moisture- and air-sensitive carbene. It can be
concluded that Suzuki reaction may be accelerated by microwave
irradiation even using aryl chlorides particularly bearing electron-
withdrawing substituents. To confirm position of NO2 group
in compound 1, crystal structural analysis was also performed
and the position of NO2 was determined as the 6 position of
the benzimidazole ring. Compounds I and 2–4 were found to
be effective in inhibiting the growth of Gram-positive bacteria
(E. faecalis and S. aureus) and yeast-like fungi (C. albicans and
C. tropicalis)
˙
¨
[18] I. Ozdemir, M. Yigˇit, E. C¸etinkaya, B. C¸etinkaya, Appl. Organomet.
Chem. 2006, 20, 187.
[19] C. O. Kappe, Angew. Chem. Int. Ed. 2004, 43, 6250.
[20] H. Prokopvova, J. Ramirez, E. Fernandez, C.O. Kappe, Tetrahedron
Lett. 2008, 49, 4831.
[21] T. N. Glasnov, S. Findenig, C.O. Kappe, Chem. Eur. J. 2009, 15, 1001.
[22] N. E. Leadbeater, M. Marco, Org.Lett. 2002, 4, 2973.
[23] K. B. Avery, W. G. Devine, C. M. Kormos, N. E. Leadbeater, Tetrahe-
dron Lett. 2009, 50, 2851.
[24] F. Chanthavong, N. E. Leadbeater, Tetrahedron Lett. 2006, 47, 1909.
[25] R. K. Arvela, N. E. Leadbeater, Org. Lett. 2005, 7, 2101.
[26] P. Appukkuttan, E. Van der Eycken, Eur. J. Org. Chem. 2008, 1133.
¨
[27] U. Yılmaz, N. S¸ireci, S. Deniz, H. Ku¨c¸u¨kbay, Appl. Organomet. Chem.
2006, 20, 254.
[28] E. Lukevics, P. Arsenyan, I. Shestakova, I. Domracheva, A. Nesterova,
O. Pudova, Eur. J. Med. Chem. 2001, 36, 507.
[29] L. Ignatovich, V. Muravenko, I. Shestakova, I. Domrachova,
J. Popelis, E. Lukevics, Appl. Organomet. Chem. 2010, 24, 158.
[30] A.K. Singh, J.W. Lown, Anti-Cancer Drug Des. 2000, 15, 265.
[31] S-T. Huang, I-J. Hsei, C. Chen, Bioorg. Med. Chem. 2006, 14, 6106.
[32] P.R. Turner, W. A. Denny, Mutation Res. 1996, 355, 141.
[33] S.A. Galal, K.H. Hegab, A.S. Kassab, M.L. Rodriguez, S. M. Kerwin,
A-M. A. El-Khamry, H.I. E. Divani, Eur. J. Med. Chem. 2009, 44, 1500.
[34] E. Carlsson, P. Lindberg, S. Unge, Chem. Britain 2002, 5, 42.
[35] S.K. Kotovskaya, Z.M. Basakova, V.N. Charushin, O.N. Chupakhin,
E. F. Belanov, N.I. Bormotov, S.M. Balakhnin, O.A. Serova, Pharm.
Chem. J. 2005, 39, 574.
Supporting Information
Supporting information can be found in the online version
of this article. CCDC holds the supplementary crystallographic
data 794 108. These data can be obtained free of charge
Cambridge Crystallographic Data Centre, 12 Union Road, Cam-
bridge CB2 1EZ, UK; Fax (+44) 1223-336-033; or email de-
[36] B. C¸etinkaya, E. C¸etinkaya, H. Ku¨c¸u¨kbay, R. Durmaz, Arzneim.
Forsch/Drug Res. 1996, 46, 1154.
[37] B. C¸etinkaya, E. C¸etinkaya, H. Ku¨c¸u¨kbay, R. Durmaz, Arzneim.
Forsch/Drug Res. 1996, 46, 821.
[38] H. Ku¨c¸u¨kbay, E. C¸etinkaya, R. Durmaz, Arzneim. Forsch/Drug Res.
1995, 45, 1331.
[39] H. Ku¨c¸u¨kbay, B. Durmaz, Arzneim. Forsch/Drug Res. 1997, 47, 667.
[40] H. Ku¨c¸u¨kbay, R. Durmaz, N. Okuyucu, S. Gu¨nal, C. Kazaz, Arzneim.
Forsch/Drug Res. 2004, 54, 64.
[41] N. S¸ireci, H. Ku¨c¸u¨kbay, M. Akkurt, S¸. P. Yalc¸ın, M. N. Tahir, H. Ott,
Acknowledgment
J. Coord. Chem. 2010, 63, 3218.
[42] SADABS: G. M. Sheldrick, 2008/1, Go¨ttingen, 2008.
[43] SIR97: A. Altomare, M. C. Burla, M. Camalli, G. L. Cascarano,
We thank Dr Holger Ott (Bruker AXS GmbH, Karlsruhe, Germany)
˙
for the data collection. We wish to thank Ino¨nu¨ University Research
C. Giacovazzo, A. Guagliardi,
A. G. G. Moliterni, G. Polidori,
Fund (BAPB-2010/124) for financial support of this study.
R. Spagna, J. Appl. Cryst. 1999, 32, 115.
[44] SHELX: G. M. Sheldrick. Acta Crystallogr. 2008, A64, 112.
[45] PLATON: A. L. Spek, J. Appl. Crystallogr. 2003, 36, 7.
[46] ORTEP-3: L. J. Farrugia, J. Appl. Crystallogr. 1997, 30, 565.
[47] National Committee for Clinical Laboratory Standards (NCCLS),
Methods for dilution antimicrobial susceptibility tests for bacteria
that grow aerobically, Approved Standard M7-A2, NCCLS Villanova,
PA, 1997.
References
[1] A. Suzuki, Pure Appl. Chem. 1985, 57, 1749.
[2] N. Miyaura, A Suzuki, Chem. Rev. 1995, 95, 2457.
[3] F. Alonso, I. P. Beletskaya, M. Yus, Tetrahedron 2008, 64, 3047.
[4] L. Yin, J. Liebscher, Chem. Rev. 2007, 107, 133.
[5] A. Tudose, L. Delaude, B. Andre, A. Demonceau, Tetrahedron Lett.
2006, 47, 8529.
[48] NCCLS, Reference method for broth dilution antifungal
susceptibilitytestingofyeasts. ProposedStandard. DocumentM27-
P. NCCLS, Villanova, PA, 1992.
¨
[49] I. Ozdemir, Y. Go¨k, N. Gu¨rbu¨z, E. C¸etinkaya, B. C¸etinkaya, Synth.
[6] L. Ackermann, R. Vicente, A. R. Kapdi, Angew. Chem. Int. Ed. 2009,
48, 9792.
Commun. 2004, 34, 4135.
c
wileyonlinelibrary.com/journal/aoc
Copyright ꢀ 2011 John Wiley & Sons, Ltd.
Appl. Organometal. Chem. 2011, 25, 366–373